References

• 1989Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?2,428 cited
• 1989Epidemiologic Study of Sleep Disturbances and Psychiatric Disorders2,252 cited
• 2005National Institutes of Health State of the Science Conference Statement745 cited
• 2003Sustained Efficacy of Eszopiclone Over 6 Months of Nightly Treatment: Results of a Randomized, Double-Blind, Placebo-Controlled Study in Adults with Chronic Insomnia630 cited
• 2003Reduction of Nightmares and Other PTSD Symptoms in Combat Veterans by Prazosin: A Placebo-Controlled Study606 cited
• 2006A Parallel Group Placebo Controlled Study of Prazosin for Trauma Nightmares and Sleep Disturbance in Combat Veterans with Post-Traumatic Stress Disorder553 cited
• 2006Eszopiclone Co-Administered With Fluoxetine in Patients With Insomnia Coexisting With Major Depressive Disorder480 cited
• 2007Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Adults with Primary Insomnia338 cited
• 2007Prazosin Effects on Objective Sleep Measures and Clinical Symptoms in Civilian Trauma Posttraumatic Stress Disorder: A Placebo-Controlled Study336 cited
• 2012Orexin receptor antagonism for treatment of insomnia322 cited
• 2007Nightly Treatment of Primary Insomnia With Eszopiclone for Six Months: Effect on Sleep, Quality of Life, and Work Limitations239 cited
• 1998Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII-R primary insomnia236 cited
• 2005An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia